Details for Patent: 8,586,551
✉ Email this page to a colleague
Which drugs does patent 8,586,551 protect, and when does it expire?
Patent 8,586,551 protects DIFICID and is included in two NDAs.
Protection for DIFICID has been extended six months for pediatric studies, as indicated by the *PED designation in the table below.
This patent has one hundred and twenty-seven patent family members in twenty-nine countries.
Summary for Patent: 8,586,551
| Title: | 18-membered macrocycles and analogs thereof |
| Abstract: | The present invention relates generally to the 18-membered macrocyclic antimicrobial agents called Tiacumicins, specifically, OPT-80 (which is composed almost entirely of the R-Tiacumicin B), pharmaceutical compositions comprising OPT-80, and methods using OPT-80. In particular, this compound is a potent drug for the treatment of bacterial infections, specifically C. difficile infections. |
| Inventor(s): | Shue; Youe-Kong (Carlsbad, CA), Hwang; Chan-Kou (San Diego, CA), Chiu; Yu-Hung (San Diego, CA), Romero; Alex (San Diego, CA), Babakhani; Farah (San Diego, CA), Sears; Pamela (San Diego, CA), Okumu; Franklin (Oakland, CA) |
| Assignee: | Optimer Pharmaceuticals, Inc. (Jersey City, NJ) |
| Application Number: | 12/551,056 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 8,586,551 |
|
Patent Claim Types: see list of patent claims | Compound; Composition; Dosage form; |
Drugs Protected by US Patent 8,586,551
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cubist Pharms Llc | DIFICID | fidaxomicin | FOR SUSPENSION;ORAL | 213138-001 | Jan 24, 2020 | RX | Yes | Yes | 8,586,551*PED | ⤷ Subscribe | ⤷ Subscribe | |||||
| Cubist Pharms Llc | DIFICID | fidaxomicin | TABLET;ORAL | 201699-001 | May 27, 2011 | RX | Yes | Yes | 8,586,551*PED | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,586,551
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 1539977 | ⤷ Subscribe | C300727 | Netherlands | ⤷ Subscribe |
| European Patent Office | 1539977 | ⤷ Subscribe | CA 2015 00020 | Denmark | ⤷ Subscribe |
| European Patent Office | 1539977 | ⤷ Subscribe | 92684 | Luxembourg | ⤷ Subscribe |
| European Patent Office | 1539977 | ⤷ Subscribe | 15C0028 | France | ⤷ Subscribe |
| European Patent Office | 1539977 | ⤷ Subscribe | 300727 | Netherlands | ⤷ Subscribe |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
